NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2558033693|gb|WLF37910|]
View 

hypothetical protein Q6H54_27750 (plasmid) [Klebsiella pneumoniae]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
AcrIF11 super family cl45570
Anti-CRISPR type I subtype F11 (AcrIF11); AcrIF11 (also known as AcrF11) is an anti-CRISPR ...
5-136 1.08e-26

Anti-CRISPR type I subtype F11 (AcrIF11); AcrIF11 (also known as AcrF11) is an anti-CRISPR (Acr) protein that was discovered via the guilt-by association (GBA) method, and subsequently confirmed by functional assays to inhibit the type I-F CRISPR-Cas system. GBA is based on the strong co-occurrence and clustering of acr and anti-CRISPR associated (aca) genes through proximity and homology searches. AcrIF11 is often associated with genes encoding DNA-binding motifs, named Aca4 through Aca7. AcrIF11 is found in over 50 species of diverse proteobacteria; given its widespread nature it was used to discover acr loci encoding acr genes inhibiting types I-C and V-A CRISPR systems, where Acr proteins had not yet been found. Structure determination revealed that AcrIF11 binds NAD. The type I-F Csy complex is a crRNA-guided surveillance complex composed of a crRNA and nine Cas proteins (one Cas8f, one Cas5f, one Cas6f, and six Cas7f), which recruits a nuclease-helicase protein Cas3 for target degradation. CRISPR-Cas immune systems are used by certain prokaryotes and archaea to resist the invasion of foreign nucleic acids such as phages or plasmids. Anti-CRISPRs are small proteins which are the natural inhibitors for CRISPR-Cas systems; encoded on bacterial and archaeal viruses, they allow the virus to evade host CRISPR-Cas systems. The CRISPR-Cas-mediated adaptive immune response can be divided into three steps, including the acquisition of spacer derived from invading nucleic acids, crRNA processing, and target degradation. Theoretically, Acr proteins could suppress any step to disrupt the CRISPR-Cas system. Acr proteins are diverse with no common sequence or structural motif, and they inhibit a wide range of CRISPR-Cas systems with various inhibition mechanisms. CRISPR-Cas systems are divided into two classes (1 and 2) and six types (class 1: types I, III and IV; class 2: types II, V and VI). Class 1 systems utilize RNA-guided complexes consisting of multiple Cas proteins as the effector proteins to recognize and cleave target DNA. Type I CRISPR-Cas systems are the most widespread in nature, and the Cas protein composition of the employed CRISPR ribonucleoprotein (crRNP) complexes differs between seven subtypes (A to F, U). Acr families are named for their type and subtype which are numbered sequentially as they are discovered.


The actual alignment was detected with superfamily member cd22580:

Pssm-ID: 439346  Cd Length: 147  Bit Score: 97.02  E-value: 1.08e-26
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2558033693   5 NVFDGLFASPERDIAASHGNTVFIYHVDDDKIAKSSDLDarfqevYAFLHNELDTAdVEEIADRVMWDNN---SDIEDFA 81
Cdd:cd22580    19 RFFEFLFFSAEVYVMTAGGHVVYSIEIDEEDIIEASDLF------YHDDAEKLEGL-VQEVADRLGIDEDtaeELLDESD 91
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2558033693  82 DILSPRLGSDINGAYSWELQRLRGRVAAYLGFDAIEMNDEYGTSYLIVN-PQIKDE 136
Cdd:cd22580    92 SVYDLDIDDEDDADASWELQRLRGRAAKKLGYRAVEMEDEQGTVYLVDMlGREAEL 147
 
Name Accession Description Interval E-value
AcrIF11 cd22580
Anti-CRISPR type I subtype F11 (AcrIF11); AcrIF11 (also known as AcrF11) is an anti-CRISPR ...
5-136 1.08e-26

Anti-CRISPR type I subtype F11 (AcrIF11); AcrIF11 (also known as AcrF11) is an anti-CRISPR (Acr) protein that was discovered via the guilt-by association (GBA) method, and subsequently confirmed by functional assays to inhibit the type I-F CRISPR-Cas system. GBA is based on the strong co-occurrence and clustering of acr and anti-CRISPR associated (aca) genes through proximity and homology searches. AcrIF11 is often associated with genes encoding DNA-binding motifs, named Aca4 through Aca7. AcrIF11 is found in over 50 species of diverse proteobacteria; given its widespread nature it was used to discover acr loci encoding acr genes inhibiting types I-C and V-A CRISPR systems, where Acr proteins had not yet been found. Structure determination revealed that AcrIF11 binds NAD. The type I-F Csy complex is a crRNA-guided surveillance complex composed of a crRNA and nine Cas proteins (one Cas8f, one Cas5f, one Cas6f, and six Cas7f), which recruits a nuclease-helicase protein Cas3 for target degradation. CRISPR-Cas immune systems are used by certain prokaryotes and archaea to resist the invasion of foreign nucleic acids such as phages or plasmids. Anti-CRISPRs are small proteins which are the natural inhibitors for CRISPR-Cas systems; encoded on bacterial and archaeal viruses, they allow the virus to evade host CRISPR-Cas systems. The CRISPR-Cas-mediated adaptive immune response can be divided into three steps, including the acquisition of spacer derived from invading nucleic acids, crRNA processing, and target degradation. Theoretically, Acr proteins could suppress any step to disrupt the CRISPR-Cas system. Acr proteins are diverse with no common sequence or structural motif, and they inhibit a wide range of CRISPR-Cas systems with various inhibition mechanisms. CRISPR-Cas systems are divided into two classes (1 and 2) and six types (class 1: types I, III and IV; class 2: types II, V and VI). Class 1 systems utilize RNA-guided complexes consisting of multiple Cas proteins as the effector proteins to recognize and cleave target DNA. Type I CRISPR-Cas systems are the most widespread in nature, and the Cas protein composition of the employed CRISPR ribonucleoprotein (crRNP) complexes differs between seven subtypes (A to F, U). Acr families are named for their type and subtype which are numbered sequentially as they are discovered.


Pssm-ID: 439346  Cd Length: 147  Bit Score: 97.02  E-value: 1.08e-26
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2558033693   5 NVFDGLFASPERDIAASHGNTVFIYHVDDDKIAKSSDLDarfqevYAFLHNELDTAdVEEIADRVMWDNN---SDIEDFA 81
Cdd:cd22580    19 RFFEFLFFSAEVYVMTAGGHVVYSIEIDEEDIIEASDLF------YHDDAEKLEGL-VQEVADRLGIDEDtaeELLDESD 91
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2558033693  82 DILSPRLGSDINGAYSWELQRLRGRVAAYLGFDAIEMNDEYGTSYLIVN-PQIKDE 136
Cdd:cd22580    92 SVYDLDIDDEDDADASWELQRLRGRAAKKLGYRAVEMEDEQGTVYLVDMlGREAEL 147
 
Name Accession Description Interval E-value
AcrIF11 cd22580
Anti-CRISPR type I subtype F11 (AcrIF11); AcrIF11 (also known as AcrF11) is an anti-CRISPR ...
5-136 1.08e-26

Anti-CRISPR type I subtype F11 (AcrIF11); AcrIF11 (also known as AcrF11) is an anti-CRISPR (Acr) protein that was discovered via the guilt-by association (GBA) method, and subsequently confirmed by functional assays to inhibit the type I-F CRISPR-Cas system. GBA is based on the strong co-occurrence and clustering of acr and anti-CRISPR associated (aca) genes through proximity and homology searches. AcrIF11 is often associated with genes encoding DNA-binding motifs, named Aca4 through Aca7. AcrIF11 is found in over 50 species of diverse proteobacteria; given its widespread nature it was used to discover acr loci encoding acr genes inhibiting types I-C and V-A CRISPR systems, where Acr proteins had not yet been found. Structure determination revealed that AcrIF11 binds NAD. The type I-F Csy complex is a crRNA-guided surveillance complex composed of a crRNA and nine Cas proteins (one Cas8f, one Cas5f, one Cas6f, and six Cas7f), which recruits a nuclease-helicase protein Cas3 for target degradation. CRISPR-Cas immune systems are used by certain prokaryotes and archaea to resist the invasion of foreign nucleic acids such as phages or plasmids. Anti-CRISPRs are small proteins which are the natural inhibitors for CRISPR-Cas systems; encoded on bacterial and archaeal viruses, they allow the virus to evade host CRISPR-Cas systems. The CRISPR-Cas-mediated adaptive immune response can be divided into three steps, including the acquisition of spacer derived from invading nucleic acids, crRNA processing, and target degradation. Theoretically, Acr proteins could suppress any step to disrupt the CRISPR-Cas system. Acr proteins are diverse with no common sequence or structural motif, and they inhibit a wide range of CRISPR-Cas systems with various inhibition mechanisms. CRISPR-Cas systems are divided into two classes (1 and 2) and six types (class 1: types I, III and IV; class 2: types II, V and VI). Class 1 systems utilize RNA-guided complexes consisting of multiple Cas proteins as the effector proteins to recognize and cleave target DNA. Type I CRISPR-Cas systems are the most widespread in nature, and the Cas protein composition of the employed CRISPR ribonucleoprotein (crRNP) complexes differs between seven subtypes (A to F, U). Acr families are named for their type and subtype which are numbered sequentially as they are discovered.


Pssm-ID: 439346  Cd Length: 147  Bit Score: 97.02  E-value: 1.08e-26
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2558033693   5 NVFDGLFASPERDIAASHGNTVFIYHVDDDKIAKSSDLDarfqevYAFLHNELDTAdVEEIADRVMWDNN---SDIEDFA 81
Cdd:cd22580    19 RFFEFLFFSAEVYVMTAGGHVVYSIEIDEEDIIEASDLF------YHDDAEKLEGL-VQEVADRLGIDEDtaeELLDESD 91
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2558033693  82 DILSPRLGSDINGAYSWELQRLRGRVAAYLGFDAIEMNDEYGTSYLIVN-PQIKDE 136
Cdd:cd22580    92 SVYDLDIDDEDDADASWELQRLRGRAAKKLGYRAVEMEDEQGTVYLVDMlGREAEL 147
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH